PF-4878691 is a Selective TLR7 Agonist with HCV Antiviral Efficacy
Chronic hepatitis C (CHC) virus infection continues to be a significant health burden, and 2–3% of the global population infected by the hepatitis C virus (HCV). The innate immune response…